Gestational weight gain and adverse birth outcomes in South African women with HIV on antiretroviral therapy and without HIV: a prospective cohort study

被引:0
作者
Madlala, Hlengiwe P. [1 ]
Myer, Landon [1 ]
Jao, Jennifer [2 ,3 ]
Geffen, Hayli [1 ]
Matjila, Mushi [4 ]
Fisher, Azetta [1 ]
Meyer, Demi [1 ]
Werner, Erika F. [5 ]
Petro, Gregory [4 ]
Cu-Uvin, Susan [6 ]
Mcgarvey, Stephen T. [7 ,8 ]
Bengtson, Angela M. [9 ]
机构
[1] Univ Cape Town, Sch Publ Hlth, Div Epidemiol & Biostat, Falmouth Bldg,Anzio Rd,Observ, ZA-7925 Cape Town, South Africa
[2] Northwestern Univ, Feinberg Sch Med, Dept Pediat, Div Infect Dis, Chicago, IL USA
[3] Northwestern Univ, Feinberg Sch Med, Dept Med, Div Infect Dis, Chicago, IL USA
[4] Univ Cape Town, Groote Schuur & New Somerset Hosp, Dept Obstet & Gynaecol, Cape Town, South Africa
[5] Tufts Univ, Sch Med, Dept Obstet & Gynaecol, Boston, MA USA
[6] Brown Univ, Warren Alpert Sch Med, Dept Obstet & Gynaecol & Med, Providence, RI USA
[7] Brown Univ, Sch Publ Hlth, Dept Epidemiol, Providence, RI USA
[8] Brown Univ, Int Hlth Inst, Sch Publ Hlth, Providence, RI USA
[9] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA USA
基金
美国国家卫生研究院;
关键词
gestational weight gain; HIV; dolutegravir; birthweight; size for gestational age; antiretroviral therapy; BODY-MASS INDEX; PREGNANCY OUTCOMES; ASSOCIATION; RISK; CARE; AGE;
D O I
10.1002/jia2.26313
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Introduction: Outside of pregnancy, evidence shows that persons with HIV initiating or switching to dolutegravir (DTG)-based antiretroviral therapy (ART) experience greater weight gain compared to those on other ART classes. However, there are few data on the impact of DTG-based ART on gestational weight gain (GWG) in sub-Saharan Africa where HIV is most common. According to the National Academy of Medicine (NAM), GWG below and above NAM guidelines is associated with adverse birth outcomes. Therefore, the objective of this study was to describe GWG by HIV status and ART regimen, and examine the associations with adverse birth outcomes. Methods: We enrolled pregnant women with HIV (WHIV) and without HIV (>= 18 years) in a peri-urban primary healthcare facility in Cape Town, South Africa between 2019 and 2022. GWG was study-measured at 24-28 (baseline) and 33-38 weeks gestation and converted to GWG rate (kg/week) in accordance with NAM guidelines. GWG z-scores were generated using the INTEGROWTH-21 and US standards to account for differing lengths of gestation. Birth outcome data were obtained from medical records. Associations of GWG z-score with adverse birth outcomes were assessed using multivariable linear or log-binomial regression. Results: Among 292 participants (48% WHIV), median age was 29 years (IQR, 25-33), median pre-pregnancy body mass index (BMI) was 31 kg/m2 (IQR, 26-36) and 20% were primiparous at baseline. The median weekly rate of GWG was 0.30 kg/week (IQR, 0.12-0.50), 35% had GWG below NAM standards (59% WHIV) and 48% had GWG above NAM standards (36% WHIV). WHIV gained weight more slowly (0.25 vs. 0.37 kg/week, p<0.01) than women without HIV. Weekly rate of GWG did not differ by ART regimen (DTG-based ART 0.25 vs. efavirenz-based ART 0.27 kg/week, p = 0.80). In multivariable analyses, GWG z-score was positively associated with continuous birth weight (mean difference = 68.53 95% CI 8.96, 128.10) and categorical high birth weight of >4000 g (RR = 2.18 95% CI 1.18, 4.01). Conclusions: Despite slower GWG among WHIV, nearly half of all women gained weight faster than recommended by the NAM. GWG was positively associated with infant birth weight. Interventions to support healthy GWG in sub-Saharan Africa are urgently needed.
引用
收藏
页数:10
相关论文
共 46 条
[1]   Dolutegravir-Based or Low-Dose Efavirenz-Based Regimen for the Treatment of HIV-1 [J].
Ayouba, A. ;
Butel, C. ;
Cournil, A. ;
Delaporte, E. ;
Eymard-Duvernay, S. ;
Granouillac, B. ;
Izard, S. ;
Lacroix, A. ;
Leroy, S. ;
Peeters, M. ;
Perrineau, S. ;
Serrano, L. ;
Reynes, J. ;
Tovar-Sanchez, T. ;
Vidal, N. ;
Fouda, P. J. ;
Kounfack, C. ;
Mougnoutou, R. ;
Olinga, J. ;
Omgba, V. ;
Ngande, S. C. Tchokonte ;
Ymele, B. ;
Mpacko, C. D. Epoupa ;
Mpoudi-Etame, M. ;
Fotso, M. ;
Moukoko, R. ;
Nke, T. ;
Akamba, A. ;
Bassega, P. Omgba ;
Fotack, S. B. Tongo ;
Ngono, S. ;
Tanga, M. ;
Aghokeng, A. ;
Ebong, E. ;
Mbesse, G. Edoul ;
Tsongo, M. ;
Mpoudi-Ngole, E. ;
Abong, T. ;
Ciaffi, L. ;
Koulla-Shiro, S. ;
Legac, S. ;
Lem, S. ;
Manirakiza, G. ;
Tata, D. Tetsa ;
Varloteaux, M. ;
Boyer, S. ;
Bousmah, M. ;
Maradan, G. ;
Nishimwe, M. L. ;
Spire, B. .
NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (09) :816-826
[2]   Relationship between pre-pregnancy maternal body mass index and infant weight trajectories in HIV-exposed and HIV-unexposed infants [J].
Bengtson, Angela M. ;
le Roux, Stanzi M. ;
Phillips, Tamsin K. ;
Brittain, Kirsty ;
Zerbe, Allison ;
Madlala, Hlengiwe P. ;
Malaba, Thokozile R. ;
Petro, Gregory ;
Abrams, Elaine J. ;
Myer, Landon .
PAEDIATRIC AND PERINATAL EPIDEMIOLOGY, 2022, 36 (04) :536-547
[3]   Greater Weight Gain in Treatment-naive Persons Starting Dolutegravir-based Antiretroviral Therapy [J].
Bourgi, Kassem ;
Rebeiro, Peter ;
Turner, Megan ;
Castilho, Jessica L. ;
Hulgan, Todd ;
Raffanti, Stephen P. ;
Koethe, John R. ;
Sterling, Timothy R. .
CLINICAL INFECTIOUS DISEASES, 2020, 70 (07) :1267-1274
[4]   The AUDIT alcohol consumption questions (AUDIT-C) - An effective brief screening test for problem drinking [J].
Bush, K ;
Kivlahan, DR ;
McDonell, MB ;
Fihn, SD ;
Bradley, KA .
ARCHIVES OF INTERNAL MEDICINE, 1998, 158 (16) :1789-1795
[5]   Weight gain during pregnancy among women initiating dolutegravir in Botswana [J].
Caniglia, Ellen C. ;
Shapiro, Roger ;
Diseko, Modiegi ;
Wylie, Blair J. ;
Zera, Chloe ;
Davey, Sonya ;
Isaacson, Arielle ;
Mayondi, Gloria ;
Mabuta, Judith ;
Luckett, Rebecca ;
Makhema, Joseph ;
Mmalane, Mompati ;
Lockman, Shahin ;
Zash, Rebecca .
ECLINICALMEDICINE, 2020, 29-30
[6]   Weight Gain After HIV Therapy Initiation: Pathophysiology and Implications [J].
Chandiwana, Nomathemba C. ;
Siedner, Mark J. ;
Marconi, Vincent C. ;
Hill, Andrew ;
Ali, Mohammed K. ;
Batterham, Rachel L. ;
Venter, Willem Daniel Francois .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2024, 109 (02) :e478-e487
[7]  
City of Cape Town, 2011, . City of Cape Town2011 census suburb Gugulethu. Data supplied by Statistics South Africa
[8]   Risks and Benefits of Dolutegravir- and Efavirenz-Based Strategies for South African Women With HIV of Child-Bearing Potential [J].
Dugdale, Caitlin M. ;
Ciaranello, Andrea L. ;
Bekker, Linda-Gail ;
Stern, Madeline E. ;
Myer, Landon ;
Wood, Robin ;
Sax, Paul E. ;
Abrams, Elaine J. ;
Freedberg, Kenneth A. ;
Walensky, Rochelle P. .
ANNALS OF INTERNAL MEDICINE, 2019, 170 (09) :614-+
[9]   Weight gain during the dolutegravir transition in the African Cohort Study [J].
Esber, Allahna L. ;
Chang, David ;
Iroezindu, Michael ;
Bahemana, Emmanuel ;
Kibuuka, Hannah ;
Owuoth, John ;
Singoei, Valentine ;
Maswai, Jonah ;
Dear, Nicole F. ;
Crowell, Trevor A. ;
Polyak, Christina S. ;
Ake, Julie A. .
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2022, 25 (04)
[10]   HIV, Subclinical Cardiovascular Disease, and Clinical Progression Insights From Immunologic Heterogeneity [J].
Feinstein, Matthew J. .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2022, 328 (10) :931-932